Brief: Bellicum Pharmaceuticals Says Board Approved Liquidation And Dissolution Of Co In Connection With Approval Of Asset Purchase Agreement

Bellicum Pharmaceuticals

22/11/2023 13:34

Nov 22 (Reuters) - Bellicum Pharmaceuticals Inc
 BLCM.PK :
    * BELLICUM PHARMACEUTICALS: ON NOV 9, AND IN CONNECTION WITH
APPROVAL OF ASSET PURCHASE AGREEMENT, BOARD APPROVED LIQUIDATION
AND DISSOLUTION OF CO
    * BELLICUM PHARMACEUTICALS INC: ON NOV 21, CO AND UNIVERSITY
OF
TEXAS M. D. ANDERSON CANCER CENTER ENTERED INTO AN ASSET
PURCHASE AGREEMENT
    * BELLICUM PHARMACEUTICALS INC: PURSUANT TO AGREEMENT MDACC
WILL
ACQUIRE SUBSTANTIALLY ALL OF COMPANY'S ASSETS
    * BELLICUM PHARMACEUTICALS: PURSUANT TO AGREEMENT, MDACC
WILL PAY
TO CO AN AMOUNT EQUAL TO $8.1 MILLION IN CASH & WILL ASSUME
CERTAIN RELATED LIABILITIES

Further company coverage:  BLCM.PK 

 ((Reuters.Briefs@thomsonreuters.com;))